Marcial García-Morillo
A5033265586- Venous Thromboembolism Diagnosis and Management
- Lymphoma Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Acute Myocardial Infarction Research
- Blood disorders and treatments
- Atrial Fibrillation Management and Outcomes
- Colorectal and Anal Carcinomas
- Neutropenia and Cancer Infections
- Chemotherapy-related skin toxicity
- Childhood Cancer Survivors' Quality of Life
- Peripheral Artery Disease Management
- Acute Ischemic Stroke Management
- Chronic Lymphocytic Leukemia Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Economic and Financial Impacts of Cancer
- Cancer Treatment and Pharmacology
- Colorectal Cancer Screening and Detection
- Cancer Risks and Factors
- Diagnosis and treatment of tuberculosis
- Birth, Development, and Health
- Blood Coagulation and Thrombosis Mechanisms
- Sepsis Diagnosis and Treatment
- Head and Neck Cancer Studies
- PI3K/AKT/mTOR signaling in cancer
Hospital Clínic de Barcelona
2017-2023
Bayer (United States)
2020
Sanofi (Mexico)
2020
Universitat de Barcelona
2018
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
2018
Background Transthoracic echocardiography ( TTE ) is often considered for risk stratification of patients with acute pulmonary embolism PE ). We sought to determine the contemporary utilization early (within 72 hours diagnosis) and explored association between findings ‐related mortality. Methods Results Data from RIETE (Registro Informatizado Enfermedad TromboEmbolica) registry, a multicenter registry consecutive , were used (2001–July 2017). generalized linear mixed model predictors...
The optimal therapy of patients with acute subsegmental pulmonary embolism (PE) is controversial.
Limited knowledge is available on the incidence of febrile neutropenia (FN) in intermediate-risk patients and rationale for use granulocyte colony-stimulating factor (G-CSF) these patients. We aimed to estimate rate at which associated with intermediate risk (10-20%) FN would develop ≥ 1 episode a commonly used chemotherapy regimen clinical practice.This prospective, real-world, observational, multinational, multicenter study (December 2016-October 2019) recruited solid tumors or...
Abstract In young patients with acute pulmonary embolism (PE), the predictive value of currently available prognostic tools has not been evaluated. Our objective was to compare 7 (GPS, PESI, sPESI, Prognostic Algorithm, PREP, shock index and RIETE) in aged <50 years. We used RIETE database, including PE from 2001 2017. The major outcome 30-day all-cause mortality. Of 34,651 PE, 5,822 (17%) were these, 83 (1.4%) died during first 30 days. Number deemed low risk was: PREP (95.9%), GPS...
Objectives: In the EXTREME trial, a combination of cisplatin or carboplatin plus 5-fluorouracil (5-FU) and cetuximab was superior to cisplatin/carboplatin 5-FU for first-line treatment recurrent metastatic head neck squamous cell carcinoma (HNSCC). With aim improving fluoropyrimidine-related tolerance without decreasing its efficacy, safety efficacy oral fluoropyrimidine tegafur were investigated. Methods: A retrospective analysis 104 patients with HNSCC conducted. Patients treated (area...
Cancer that occurs inside the pregnant or during first postpartum year (or throughout lactation time) is considered gestational. The diagnosis of this entity intrinsically accompanied by ethical problems when making clinical decisions about disease and newborn future [1,2]. Nowadays a modern medical treatment achieves treat cancer with same prognosis than no-pregnant population childbirth without any sequela. Spanish consensus different specializations (Surgery, gynecology, radiology...